Chiome Bioscience (TSE:4583) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 25, 2026)


TSE:4583 Chiome Bioscience Inc TSE:4583
50 GF Score
Price 円66.00
GF Value 円82.68
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Chiome Bioscience Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Chiome Bioscience's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

TSE:4583 vs VRTX, REGN, ALNY: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Chiome Bioscience's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Chiome Bioscience Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Chiome Bioscience's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Chiome Bioscience's Margin of Safety % (DCF Earnings Based) falls into.


TSE:4583
50GF Score
Chiome Bioscience Inc TSE:4583
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Chiome Bioscience (TSE:4583) Overvalued in 2026?

Based on GuruFocus' analysis, Chiome Bioscience stock appears to be undervalued. The current stock price of 円66.00 is trading 20.2% below its estimated GF Value™ of 円82.68. GuruFocus considers Chiome Bioscience to be Modestly Undervalued.

Key valuation signals for TSE:4583:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: 円82.68 vs. price of 円66.00 (20.2% below fair value)
  • GF Score™: 50/100 with 2 warning signs

No single metric tells the full story. See the TSE:4583 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Chiome Bioscience Business Description

Address 3-12-1 Honmachi, No. 6, Sumitomo Fudosan Nishi Shinjuku Building, Shibuya-ku, Tokyo, JPN, 151-0071
Chiome Bioscience Inc is engaged in the discovery and development of antibody drugs, focusing on early-stage research and initial clinical trials. The company operates through two reportable segments: the Drug Discovery segment and the Drug Discovery Support segment. The Drug Discovery segment conducts research on antibody creation for diseases with high unmet medical needs and aims to generate revenue through licensing agreements, upfront payments, milestone payments, and royalties. The Drug Discovery Support segment provides services such as antibody production and related support using proprietary antibody technologies, catering to pharmaceutical and diagnostic companies as well as academic institutions.
50GF Score

Get the complete analysis for TSE:4583

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円66.00
Price
円82.68
GF Value